Literature DB >> 11380414

Long-term outcome of patients surviving for more than ten years following treatment for acute leukaemia.

I N Micallef1, A Z Rohatiner, M Carter, M Boyle, S Slater, J A Amess, T A Lister.   

Abstract

Between 1972 and 1988, 832 consecutive patients were treated for acute leukaemia at St. Bartholomew's Hospital; a retrospective analysis has been conducted to determine the clinical course and outcome for 101 who have survived > or = 10 years following treatment. At a median follow-up of 16 years (range 10-28 years), 86 patients (86 out of 834 total, 11%) were still alive. Long-term follow-up of patients who have survived > or = 10 years following treatment for acute leukaemia revealed that most patients were in normal health, although a significant number of complications had occurred.

Entities:  

Mesh:

Year:  2001        PMID: 11380414     DOI: 10.1046/j.1365-2141.2001.02788.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Long-term survivors with adult acute leukemia in complete remission: complications and return to work.

Authors:  Yuhko Suzuki-Tsunoda; Setsuko Kawamura; Kenichi Tsushima; Yoshiko Tamai; Hideki Takami; Akihiro Munakata; Masashi Tsunoda
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

2.  Azelaic Acid Exerts Antileukemic Activity in Acute Myeloid Leukemia.

Authors:  Yunbao Pan; Dong Liu; Yongchang Wei; Dan Su; Chenyang Lu; Yanchao Hu; Fuling Zhou
Journal:  Front Pharmacol       Date:  2017-06-12       Impact factor: 5.810

3.  Anti-Cancerous Effect of Inonotus taiwanensis Polysaccharide Extract on Human Acute Monocytic Leukemia Cells through ROS-Independent Intrinsic Mitochondrial Pathway.

Authors:  Tsai-Ling Chao; Ting-Yin Wang; Chin-Huei Lee; Shuenn-Jiun Yiin; Chun-Te Ho; Sheng-Hua Wu; Huey-Ling You; Chi-Liang Chern
Journal:  Int J Mol Sci       Date:  2018-01-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.